Frankfurt - Delayed Quote EUR
Larimar Therapeutics, Inc. (ZA71.F)
1.9400
-0.1400
(-6.73%)
At close: April 24 at 8:04:42 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
200,225
95,935
126,405
78,667
Total Liabilities Net Minority Interest
28,413
14,215
15,502
14,254
Total Equity Gross Minority Interest
171,812
81,720
110,903
64,413
Total Capitalization
171,812
81,720
110,903
64,413
Common Stock Equity
171,812
81,720
110,903
64,413
Capital Lease Obligations
5,117
5,546
5,408
6,002
Net Tangible Assets
171,812
81,720
110,903
64,413
Working Capital
170,948
80,669
110,034
63,358
Invested Capital
171,812
81,720
110,903
64,413
Tangible Book Value
171,812
81,720
110,903
64,413
Total Debt
5,117
5,546
5,408
6,002
Share Issued
63,806.6280
43,909.0690
43,269.2000
17,710.4500
Ordinary Shares Number
63,806.6280
43,909.0690
43,269.2000
17,710.4500
12/31/2021 - 6/3/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2BO.F Serina Therapeutics Inc. R
5.10
+10.87%
2GH.F Merus N.V.
32.60
-10.44%
PCJ.F Abeona Therapeutics Inc.
4.5000
-2.17%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
NEXI NexImmune, Inc.
0.0001
0.00%
SER Serina Therapeutics, Inc.
6.09
+5.36%
VALN Valneva SE
6.99
+1.75%
SION Sionna Therapeutics, Inc.
12.60
-3.74%
AARD Aardvark Therapeutics, Inc.
8.22
-3.52%
KALV KalVista Pharmaceuticals, Inc.
12.88
+3.45%